{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:23:35Z","timestamp":1790497415360,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/bcr3336","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T11:15:00Z","timestamp":1355224500000},"source":"Crossref","is-referenced-by-count":35,"title":["Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality"],"prefix":"10.1186","volume":"14","author":[{"given":"Michelle D","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"3148_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2796.2005.01519.x","volume":"258","author":"D Pereg","year":"2005","unstructured":"Pereg D, Lishner M: Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J Intern Med. 2005, 258: 115-123. 10.1111\/j.1365-2796.2005.01519.x.","journal-title":"J Intern Med"},{"key":"3148_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bjc.1983.251","volume":"48","author":"RA Karmali","year":"1983","unstructured":"Karmali RA, Welt S, Thaler HT, Lefevre F: Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer. 1983, 48: 689-696. 10.1038\/bjc.1983.251.","journal-title":"Br J Cancer"},{"key":"3148_CR3","first-page":"625","volume":"62","author":"KM Leahy","year":"2002","unstructured":"Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 2002, 62: 625-631.","journal-title":"Cancer Res"},{"key":"3148_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","volume":"83","author":"M Tsujii","year":"1995","unstructured":"Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995, 83: 493-501. 10.1016\/0092-8674(95)90127-2.","journal-title":"Cell"},{"key":"3148_CR5","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI: Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA. 2004, 291: 2433-2440. 10.1001\/jama.291.20.2433.","journal-title":"JAMA"},{"key":"3148_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1158\/1055-9965.EPI-09-0975","volume":"19","author":"MA Gates","year":"2010","unstructured":"Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE: Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2010, 19: 1033-1041. 10.1158\/1055-9965.EPI-09-0975.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3148_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10549-011-1651-7","volume":"130","author":"MD Holmes","year":"2011","unstructured":"Holmes MD, Chen WY, Schnitt SJ, Collins L, Colditz GA, Hankinson SE, Tamimi RM: COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011, 130: 657-662. 10.1007\/s10549-011-1651-7.","journal-title":"Breast Cancer Res Treat"},{"key":"3148_CR8","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-03-0463","volume":"10","author":"CT Dang","year":"2004","unstructured":"Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, Seidman AD, D'Andrea GM, Theodoulou M, Panageas KS, Norton L, Hudis CA: Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments. Clin Cancer Res. 2004, 10: 4062-4067. 10.1158\/1078-0432.CCR-03-0463.","journal-title":"Clin Cancer Res"},{"key":"3148_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B: Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011, 11: 123-134. 10.1038\/nrc3004.","journal-title":"Nat Rev Cancer"},{"key":"3148_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10552-007-9003-y","volume":"18","author":"ML Kwan","year":"2007","unstructured":"Kwan ML, Habel LA, Slattery ML, Caan B: NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007, 18: 613-620. 10.1007\/s10552-007-9003-y.","journal-title":"Cancer Causes Control"},{"key":"3148_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-006-9277-x","volume":"101","author":"CK Blair","year":"2007","unstructured":"Blair CK, Sweeney C, Anderson KE, Folsom AR: NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat. 2007, 101: 191-197. 10.1007\/s10549-006-9277-x.","journal-title":"Breast Cancer Res Treat"},{"key":"3148_CR12","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE: Aspirin intake and survival after breast cancer. J Clin Oncol. 2010, 28: 1467-1472. 10.1200\/JCO.2009.22.7918.","journal-title":"J Clin Oncol"},{"key":"3148_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/jnci\/djn347","volume":"100","author":"LR Howe","year":"2008","unstructured":"Howe LR, Lippman SM: Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst. 2008, 100: 1420-1423. 10.1093\/jnci\/djn347.","journal-title":"J Natl Cancer Inst"},{"key":"3148_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1158\/1055-9965.EPI-11-1012","volume":"21","author":"Y Li","year":"2012","unstructured":"Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL: Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2012, 21: 239-242. 10.1158\/1055-9965.EPI-11-1012.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3148_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z: Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012, 379: 1591-1601. 10.1016\/S0140-6736(12)60209-8.","journal-title":"Lancet"},{"key":"3148_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra AM, Rothwell PM: Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012, 13: 518-527. 10.1016\/S1470-2045(12)70112-2.","journal-title":"Lancet Oncol"},{"key":"3148_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrc1820","volume":"6","author":"MH Antoni","year":"2006","unstructured":"Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK: The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006, 6: 240-248. 10.1038\/nrc1820.","journal-title":"Nat Rev Cancer"},{"key":"3148_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.01.009","volume":"130","author":"C Vaklavas","year":"2011","unstructured":"Vaklavas C, Chatzizisis YS, Tsimberidou AM: Common cardiovascular medications in cancer therapeutics. Pharmacol Ther. 2011, 130: 177-190. 10.1016\/j.pharmthera.2011.01.009.","journal-title":"Pharmacol Ther"},{"key":"3148_CR19","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, Sood AK, Cole SW: The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010, 70: 7042-7052. 10.1158\/0008-5472.CAN-10-0522.","journal-title":"Cancer Res"},{"key":"3148_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01612908","volume":"116","author":"B Vandewalle","year":"1990","unstructured":"Vandewalle B, Revillion F, Lefebvre J: Functional beta-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol. 1990, 116: 303-306. 10.1007\/BF01612908.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3148_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.18632\/oncotarget.197","volume":"1","author":"DG Powe","year":"2010","unstructured":"Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, Entschladen F: Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010, 1: 628-638.","journal-title":"Oncotarget"},{"key":"3148_CR22","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD, Hortobagyi GN, Gonzalez-Angulo AM: Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011, 29: 2645-2652. 10.1200\/JCO.2010.33.4441.","journal-title":"J Clin Oncol"},{"key":"3148_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-011-1505-3","volume":"129","author":"PA Ganz","year":"2011","unstructured":"Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW: Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011, 129: 549-556. 10.1007\/s10549-011-1505-3.","journal-title":"Breast Cancer Res Treat"},{"key":"3148_CR24","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K: Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol. 2011, 29: 2635-2644. 10.1200\/JCO.2010.33.5422.","journal-title":"J Clin Oncol"},{"key":"3148_CR25","first-page":"573","volume":"63","author":"WP Koh","year":"2003","unstructured":"Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP, Yu MC: Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res. 2003, 63: 573-578.","journal-title":"Cancer Res"},{"key":"3148_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/carcin\/bgh309","volume":"26","author":"WP Koh","year":"2005","unstructured":"Koh WP, Yuan JM, Van Den Berg D, Lee HP, Yu MC: Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis. 2005, 26: 459-464.","journal-title":"Carcinogenesis"},{"key":"3148_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ygyno.2008.02.019","volume":"109","author":"D Herr","year":"2008","unstructured":"Herr D, Rodewald M, Fraser HM, Hack G, Konrad R, Kreienberg R, Wulff C: Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. Gynecol Oncol. 2008, 109: 418-425. 10.1016\/j.ygyno.2008.02.019.","journal-title":"Gynecol Oncol"},{"key":"3148_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jcp.10313","volume":"196","author":"S Greco","year":"2003","unstructured":"Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S: Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol. 2003, 196: 370-377. 10.1002\/jcp.10313.","journal-title":"J Cell Physiol"},{"key":"3148_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jcp.22209","volume":"225","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Chen X, Cai L, Yang Y, Sui G, Fu S: Angiotensin II\/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase\/Akt pathway. J Cell Physiol. 2010, 225: 168-173. 10.1002\/jcp.22209.","journal-title":"J Cell Physiol"},{"key":"3148_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/07357907.2011.616252","volume":"29","author":"YK Chae","year":"2011","unstructured":"Chae YK, Valsecchi ME, Kim J, Bianchi AL, Khemasuwan D, Desai A, Tester W: Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and\/or statins. Cancer Invest. 2011, 29: 585-593. 10.3109\/07357907.2011.616252.","journal-title":"Cancer Invest"},{"key":"3148_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.onc.1209117","volume":"25","author":"UK Khanzada","year":"2006","unstructured":"Khanzada UK, Pardo OE, Meier C, Downward J, Seckl MJ, Arcaro A: Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling. Oncogene. 2006, 25: 877-887. 10.1038\/sj.onc.1209117.","journal-title":"Oncogene"},{"key":"3148_CR32","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1158\/0008-5472.CAN-07-5807","volume":"68","author":"YC Lin","year":"2008","unstructured":"Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH, Chen CC: Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1\/2. Cancer Res. 2008, 68: 2375-2383. 10.1158\/0008-5472.CAN-07-5807.","journal-title":"Cancer Res"},{"key":"3148_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10549-007-9683-8","volume":"109","author":"ML Kwan","year":"2008","unstructured":"Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B: Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008, 109: 573-579. 10.1007\/s10549-007-9683-8.","journal-title":"Breast Cancer Res Treat"},{"key":"3148_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/jnci\/djr291","volume":"103","author":"TP Ahern","year":"2011","unstructured":"Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sorensen HT, Lash TL: Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst. 2011, 103: 1461-1468. 10.1093\/jnci\/djr291.","journal-title":"J Natl Cancer Inst"},{"key":"3148_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1056\/NEJMp1113112","volume":"366","author":"CA Jackevicius","year":"2012","unstructured":"Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM: Generic atorvastatin and health care costs. N Engl J Med. 2012, 366: 201-204. 10.1056\/NEJMp1113112.","journal-title":"N Engl J Med"},{"key":"3148_CR36","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1055-9965.EPI-05-0027","volume":"14","author":"RE Duncan","year":"2005","unstructured":"Duncan RE, El-Sohemy A, Archer MC: Statins and cancer development. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1897-1898. 10.1158\/1055-9965.EPI-05-0027.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3148_CR37","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1158\/0008-5472.CAN-05-3544","volume":"66","author":"S Frese","year":"2006","unstructured":"Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA: Cardiac glycosides initiate Apo2L\/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res. 2006, 66: 5867-5874. 10.1158\/0008-5472.CAN-05-3544.","journal-title":"Cancer Res"},{"key":"3148_CR38","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1248\/bpb.29.1493","volume":"29","author":"K Bielawski","year":"2006","unstructured":"Bielawski K, Winnicka K, Bielawska A: Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull. 2006, 29: 1493-1497. 10.1248\/bpb.29.1493.","journal-title":"Biol Pharm Bull"},{"key":"3148_CR39","first-page":"493","volume":"6","author":"B Stenkvist","year":"1999","unstructured":"Stenkvist B: Is digitalis a therapy for breast carcinoma?. Oncol Rep. 1999, 6: 493-496.","journal-title":"Oncol Rep"},{"key":"3148_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","volume":"3","author":"A Decensi","year":"2010","unstructured":"Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila Pa). 2010, 3: 1451-1461. 10.1158\/1940-6207.CAPR-10-0157.","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"3148_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.20.1.42","volume":"20","author":"PJ Goodwin","year":"2002","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002, 20: 42-51. 10.1200\/JCO.20.1.42.","journal-title":"J Clin Oncol"},{"key":"3148_CR42","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/annonc\/mdr534","volume":"23","author":"X He","year":"2012","unstructured":"He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC: Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Ann Oncol. 2012, 23: 1771-1780. 10.1093\/annonc\/mdr534.","journal-title":"Ann Oncol"},{"key":"3148_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","volume":"29","author":"KS Peairs","year":"2011","unstructured":"Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Derr RL, Brancati FL, Wolff AC: Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011, 29: 40-46. 10.1200\/JCO.2009.27.3011.","journal-title":"J Clin Oncol"},{"key":"3148_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/dc11-1313","volume":"35","author":"CJ Currie","year":"2012","unstructured":"Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL: Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care. 2012, 35: 299-304. 10.2337\/dc11-1313.","journal-title":"Diabetes Care"},{"key":"3148_CR45","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","volume":"27","author":"S Jiralerspong","year":"2009","unstructured":"Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009, 27: 3297-3302. 10.1200\/JCO.2009.19.6410.","journal-title":"J Clin Oncol"},{"key":"3148_CR46","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/cncr.26439","volume":"118","author":"S Bayraktar","year":"2012","unstructured":"Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM: Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer. 2012, 118: 1202-1211. 10.1002\/cncr.26439.","journal-title":"Cancer"},{"key":"3148_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1741-7015-4-22","volume":"4","author":"S Hernandez-Diaz","year":"2006","unstructured":"Hernandez-Diaz S, Garcia Rodriguez LA: Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med. 2006, 4: 22-10.1186\/1741-7015-4-22.","journal-title":"BMC Med"},{"key":"3148_CR48","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","volume":"280","author":"J He","year":"1998","unstructured":"He J, Whelton PK, Vu B, Klag MJ: Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998, 280: 1930-1935. 10.1001\/jama.280.22.1930.","journal-title":"JAMA"},{"key":"3148_CR49","volume-title":"BMJ Case Rep","author":"T Hashmi","year":"2011","unstructured":"Hashmi T: Probable hepatotoxicity associated with the use of metformin in type 2 diabetes. BMJ Case Rep. 2011"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr3336\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T11:59:05Z","timestamp":1484913545000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr3336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1186\/bcr3336","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"216"}}